Gene expression patterns within cell lines are predictive of chemosensitivity

Por Ring, Brian Z, Chang, Stella, Ring, L Winston, Seitz, Robert S, Ross, Douglas T
Publicado em 2008

Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients

Por Wang, Xi, Ring, Brian Z., Seitz, Robert S., Ross, Douglas T., Woolf, Kirsten, Beck, Rodney A., Hicks, David G., Yeh, Shuyuan
Publicado no BMC Clin Pathol (2015)

A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers

Por Frolova, Natalya, Edmonds, Mick D., Bodenstine, Thomas M., Seitz, Robert, Johnson, Martin R., Feng, Rui, Welch, Danny R., Frost, Andra R.
Publicado em 2009

Chemosensitivity and Stratification by a Five Monoclonal Antibody Immunohistochemistry Test in the NSABP B-14 and B-20 Trials

Por Ross, Douglas T., Kim, Chung-yeul, Tang, Gong, Bohn, Olga L., Beck, Rodney A., Ring, Brian Z., Seitz, Robert S., Paik, Soonmyung, Costantino, Joseph P., Wolmark, Norman
Publicado em 2008

Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

Por Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Publicado no BMC Cancer (2016)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients

Por Ring, Brian Z., Hout, David R., Morris, Stephan W., Lawrence, Kasey, Schweitzer, Brock L., Bailey, Daniel B., Lehmann, Brian D., Pietenpol, Jennifer A., Seitz, Robert S.
Publicado no BMC Cancer (2016)

Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue

Por Jovanović, Bojana, Sheng, Quanhu, Seitz, Robert S., Lawrence, Kasey D., Morris, Stephan W., Thomas, Lance R., Hout, David R., Schweitzer, Brock L., Guo, Yan, Pietenpol, Jennifer A., Lehmann, Brian D.
Publicado no BMC Cancer (2017)

TLE3 as a candidate biomarker of response to taxane therapy

Por Kulkarni, Swati A, Hicks, David G, Watroba, Nancy L, Murekeyisoni, Christine, Hwang, Helena, Khoury, Thaer, Beck, Rodney A, Ring, Brian Z, Estopinal, Noel C, Schreeder, Marshall T, Seitz, Robert S, Ross, Douglas T
Publicado em 2009

Mammostrat(® )as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy

Por Bartlett, John MS, Thomas, Jeremy, Ross, Douglas T, Seitz, Robert S, Ring, Brian Z, Beck, Rodney A, Pedersen, Hans Christian, Munro, Alison, Kunkler, Ian H, Campbell, Fiona M, Jack, Wilma, Kerr, Gillian R, Johnstone, Laura, Cameron, David A, Chetty, Udi
Publicado em 2010

The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

Por Hicks, David G, Janarthanan, Bagi R, Vardarajan, Ramya, Kulkarni, Swati A, Khoury, Thaer, Dim, Daniel, Budd, G Thomas, Yoder, Brian J, Tubbs, Raymond, Schreeder, Marshall T, Estopinal, Noel C, Beck, Rodney A, Wang, Yanling, Ring, Brian Z, Seitz, Robert S, Ross, Douglas T
Publicado em 2010